Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1089]
News [2702]
Articles [179]
Editorials [9]
Conferences [110]
elearning [25]
ASCO 2026: Potential new targeted treatment option for people with localised high-risk prostate cancer
ASCO 2026: Potential new targeted treatment option for people with localised high-risk prostate cancer
FDA approves durvalumab in combination with BCG for high-risk non-muscle invasive bladder cancer
FDA approves durvalumab in combination with BCG for high-risk non-muscle invasive bladder cancer
Researchers develop a new sensor that could enable earlier detection of bladder cancer
Researchers develop a new sensor that could enable earlier detection of bladder cancer
Positive EU CHMP opinion for pembrolizumab in combination with enfortumab vedotin-ejfv as perioperative treatment in muscle-invasive bladder cancer
Positive EU CHMP opinion for pembrolizumab in combination with enfortumab vedotin-ejfv as perioperative treatment...
ASCO 2026: Less cognitive decline with darolutamide treatment than enzalutamide in people with advanced prostate cancer
ASCO 2026: Less cognitive decline with darolutamide treatment than enzalutamide in people with advanced prostate...
Study identifies new marker to find patients with advanced prostate cancer more likely to benefit from combination immunotherapy
Study identifies new marker to find patients with advanced prostate cancer more likely to benefit from combination...
ESTRO 2026:AI tool for radiotherapy can support the global effort to eliminate cervical cancer
ESTRO 2026:AI tool for radiotherapy can support the global effort to eliminate cervical cancer
Novel molecular marker may improve prostate cancer treatment
Novel molecular marker may improve prostate cancer treatment
FDA approves atezolizumab for adjuvant treatment of muscle invasive bladder cancer in patients with molecular residual disease
FDA approves atezolizumab for adjuvant treatment of muscle invasive bladder cancer in patients with molecular...
Experimental drug shows promise for some patients with advanced prostate cancer
Experimental drug shows promise for some patients with advanced prostate cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation